Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report

Muhannad A Alsemari1, Hakeam A Hakeam2, Hussain Alsalman3

  • 1Department of Surgery, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.

Summary

High-dose tigecycline, used for multidrug-resistant bacteria, can cause reversible skin hyperpigmentation. This previously unreported side effect emerged rapidly in a patient receiving this potent antibiotic therapy.